FTC weighs in on AbbVie antitrust litigation

22-06-2023

Muireann Bolger

FTC weighs in on AbbVie antitrust litigation

Valeriya Zankovych / Shutterstock.com

Commission argues that a New York federal court erred in its finding that deals between an AbbVie unit and generic manufacturers were justified | US Supreme Court previously ruled that “unjustified” reverse payments can violate the antitrust laws.


AbbVie, FTC, antitrust, litigation, generics, US Court of Appeals for the Second Circuit, amicus brief, Bystolic, US Supreme Court, plaintiffs

LSIPR